Candel Therapeutics, Inc. (NASDAQ:CADL) currently has 78 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 31 Dec, 2025 | 8,234,299 | 914 | 0.01% | $46,523,790.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 2,861,689 | 482,359 | 20.27% | $16,168,544.00 |
| ACORN CAPITAL ADVISORS, LLC | 31 Dec, 2025 | 2,580,517 | 0 | 0.00% | $14,579,921.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 2,305,060 | 297,948 | 14.84% | $13,023,588.00 |
| Portolan Capital Management, LLC | 31 Dec, 2025 | 1,695,367 | 311,225 | 22.49% | $9,578,824.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 977,512 | 49,315 | 5.31% | $5,523,837.00 |
| STATE STREET CORP | 31 Dec, 2025 | 792,218 | 103,452 | 15.02% | $4,476,032.00 |
| Halter Ferguson Financial Inc. | 31 Dec, 2025 | 748,055 | 50,051 | 7.17% | $4,226,509.00 |
| Sands Capital Alternatives, LLC | 31 Dec, 2025 | 405,837 | 0 | 0.00% | $2,292,979.00 |
| NORTHERN TRUST CORP | 31 Dec, 2025 | 295,438 | -11,337 | -3.70% | $1,669,225.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 226,356 | -25,935 | -10.28% | $1,278,911.00 |
| Tanager Wealth Management LLP | 31 Dec, 2025 | 198,175 | 0 | 0.00% | $1,119,689.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 143,199 | 32,799 | 29.71% | $809,075.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 137,408 | -86,413 | -38.61% | $776,355.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 134,031 | 58,090 | 76.49% | $757,275.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 121,004 | 0 | 0.00% | $683,673.00 |
| UBS Group AG | 31 Dec, 2025 | 104,339 | 10,268 | 10.92% | $589,515.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 99,200 | -36,916 | -27.12% | $560,480.00 |
| Bank of New York Mellon Corp | 31 Dec, 2025 | 95,208 | 639 | 0.68% | $537,924.00 |
| Nuveen, LLC | 31 Dec, 2025 | 92,482 | -117,180 | -55.89% | $522,523.00 |